INT Overview

  • Founded
  • 2000

Founded
  • Status
  • Private

  • Employees
  • 21

Employees
  • Latest Deal Type
  • Debt - PPP

  • Investors
  • 1

INT General Information

Description

Developer of diagnostic devices designed to automate the processing of complex biological analysis. The company's diagnostic device specializes in the research and development of tools for diagnostics sample processing and detecting the presence of biological agents in DNA using electronic DNA sensors and also uses a technology that integrates deoxyribonucleic acid (DNA) molecules and electronic circuits, enabling medical professionals to detect diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Commercial Products
Primary Office
  • 999 Lehigh Station Road
  • Suite 200
  • Henrietta, NY 14467
  • United States
+1 (585) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 30-Apr-2020 00.00 Completed Generating Revenue
3. Seed Round 16-Mar-2017 00.00 00.00 Completed Generating Revenue
2. Angel (individual) Completed Generating Revenue
1. Grant 28-Mar-2005 $500K Completed Generating Revenue
To view INT’s complete valuation and funding history, request access »

INT Patents

INT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3965935-A1 Systems and methods for analyzing rna transcripts Pending 10-May-2019 00000000000
CA-3139860-A1 Systems and methods for analyzing rna transcripts Pending 10-May-2019 00000000000
US-20200332362-A1 Systems and methods for determining risk or diagnosis of a neurodegenerative disease Inactive 10-May-2018 0000000000
US-20190285639-A1 Systems and methods for optical sensing of biomolecular targets Pending 26-Oct-2016 0000000000
EP-3532821-A4 Systems and methods for optical sensing of biomolecular targets Pending 26-Oct-2016 G01N15/1434 0
To view INT’s complete patent history, request access »

INT Executive Team (7)

Name Title Board Seat Contact Info
Ragu Raman Chief Executive Officer, President and Board Member
Michael Connolly Ph.D Founder & Board Member
Donald Noble Chief Financial Officer and Vice President of Finance and Corporate Secretary
You’re viewing 3 of 7 executive team members. Get the full list »

INT Board Members (10)

Name Representing Role Since
David Franz Ph.D INT Board Member 000 0000
Dennis Reimer INT Board Member 000 0000
J. Michael Holloway INT Board Member 000 0000
John Hamre Ph.D Self Board Member 000 0000
John Noonan INT Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

INT Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

INT Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
To view INT’s complete investors history, request access »